Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | EPRS1 | P07814 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CCR1 | P32246 | 1/20 | 0.31 |
| ▸ | CCR5 | P51681 | 1/20 | 0.31 |
| ▸ | CCR8 | P51685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16518366 | 0.84 | KMT2A (0.38) | ALDH1A1EPRS1HPGDTSHR | |
| SCHEMBL29380074 | 0.82 | ALDH1A1 (0.42) | ALDH1A1CYP3A4TSHRMAPK1 | |
| SCHEMBL1590024 | 0.82 | ALDH1A1 (0.42) | ALDH1A1CYP3A4TSHRMAPK1 | |
| SCHEMBL24665529 | 0.79 | HPRT1 (0.58) | ALDH1A1CYP3A4HPGDTSHRMAPK1 | |
| SCHEMBL18370284 | 0.76 | PARP1 (0.56) | ALDH1A1CYP3A4HPGDCASP1RAB9A | |
| SCHEMBL18370996 | 0.76 | NOS2 (0.45) | ALDH1A1CCR1CCR5CCR8 | |
| SCHEMBL18370280 | 0.76 | LMNA (0.46) | ALDH1A1CYP3A4MAPK1CCR1CCR5 | |
| SCHEMBL6042829 | 0.75 | CYP2A6 (0.43) | ALDH1A1EPRS1HPGDMAPK1L3MBTL1 | |
| SCHEMBL4164226 | 0.75 | MEN1 (0.32) | TSHR | |
| SCHEMBL4165391 | 0.75 | ESR2 (0.41) | ALDH1A1HPGDTSHRHSD17B10L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160369045-A1 | NOVEL FUSED NAPHTHALENE CYCLOHETERO RING COMPOUNDS, AND METHODS AND USES THEREOF | CORNING INC (US) | 2016-12-22 | — | — | US | disclosed |
| US-20150045560-A1 | NOVEL FUSED NAPHTHALENE CYCLOHETERO RING COMPOUNDS, AND METHODS AND USES THEREOF | CORNING INCORPORATED | 2015-02-12 | — | — | US | disclosed |
| US-20070287821-A1 | Synthesis of Polynaphthalenes and Their Use | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150045560-A1 | NOVEL FUSED NAPHTHALENE CYCLOHETERO RING COMPOUNDS, AND METHODS AND USES THEREOF | FDPS, PPOX, DHPS | ALDH1A1 2064/4885EPRS1 723/4885CYP3A4 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.